Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Chronic hemodialysis Patients with Coronary Artery Disease
Not Applicable
- Conditions
- Ischemic Heart Disease
- Registration Number
- JPRN-UMIN000022139
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with contraindications to prasugrel 2. Patients who have severe liver problem 3. Weight is 50 kg or less 4. low platelet counts (less than 10*10^4) 5. Pregnant 6. Lactating 7. Patients who are taking anticoagulants 8. Patients who are planned to administer thrombolytic agents 9. Patients scheduled for PCI or coronary artery bypass graft during this study 10. Patents who are planed to change hemodialysis characteristics during this study 11. Patients who are taking ticlopidine or cilostazol 12. Patients judged as inappropriate for trial entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method